During the past decade, National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders" are "ALS" (2 trials), "Alzheimer Disease" (2 trials) and "Amyotrophic Lateral Sclerosis (ALS)" (1 trials). Many other conditions were trialed in "National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "MT-1186" (3 trials), "bapineuzumab" (2 trials), "placebo" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders" are 5 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".